OSENI 25-30 MG TABLET

alogliptin and pioglitazone
$12.3977per EA

Strength

25; 30 mg/1; mg/1

NDC

64764025303

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/3/2019

Approval Type

New Drug (NDA)

FDA Application

NDA022426

On Market Since

1/25/2013

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+49.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.